EXPANDABLE DEVICES AND ASSOCIATED SYSTEMS AND METHODS

    公开(公告)号:US20230277187A1

    公开(公告)日:2023-09-07

    申请号:US17653269

    申请日:2022-03-02

    Applicant: Covidien LP

    CPC classification number: A61B17/12118 A61B17/12168 A61B2017/1205

    Abstract: Expandable devices for occluding bifurcation aneurysms are disclosed herein. Several of the embodiments are directed towards an expandable device comprising a mesh configured to be deployed at a treatment site including blood vessel bifurcation of a human patient so that the mesh extends across a neck of an aneurysm and prevents or limits blood flow through the mesh and into the aneurysm. The mesh can comprise one or more circumferentially discontinuous portions so that, when the device is deployed at the treatment site, the device does not substantially impede flow from a parent blood vessel to two or more branching blood vessels. Systems and methods for delivering an expandable device of the present technology are also disclosed herein.

    Retrieval of material from corporeal lumens

    公开(公告)号:US11523838B2

    公开(公告)日:2022-12-13

    申请号:US16439642

    申请日:2019-06-12

    Applicant: Covidien LP

    Abstract: Retrieval of material from vessel lumens can be improved by use of a distal element comprising an expandable mesh, a treatment device includes an elongated member having a proximal portion and a distal portion configured to be positioned within a blood vessel at a treatment site at or near a thrombus. A distal element comprising an expandable mesh is coupled to the distal portion of the elongated member via a connection assembly. In an expanded state, at least a portion of the mesh is configured to be in apposition with the blood vessel wall at the treatment site to anchor or stabilize the elongated member with respect to the blood vessel. The distal element can be electrically coupled to an extracorporeal current generator.

    VASCULAR REMODELING DEVICE
    18.
    发明申请

    公开(公告)号:US20210000624A1

    公开(公告)日:2021-01-07

    申请号:US16948385

    申请日:2020-09-16

    Applicant: Covidien LP

    Abstract: Vascular remodeling devices can include a proximal section, an intermediate section, and a distal section. During deployment, the proximal section can expand from a compressed delivery state to an expanded state and anchor the device in an afferent vessel of a bifurcation. The distal section expands from the compressed delivery state to an expanded state that may be substantially planar, approximately semi-spherical, umbrella shaped, or reverse umbrella shaped. The distal section is positioned in a bifurcation junction across the neck of an aneurysm or within an aneurysm. The intermediate section allows perfusion to efferent vessels. Before or after the device is in position, embolic material may be used to treat the aneurysm. The distal section can act as a scaffolding to prevent herniation of the embolic material. The device can be used for clot retrieval with integral distal embolic protection.

    ANTI-THROMBOGENIC MEDICAL DEVICES
    19.
    发明申请

    公开(公告)号:US20200323664A1

    公开(公告)日:2020-10-15

    申请号:US16913871

    申请日:2020-06-26

    Applicant: Covidien LP

    Abstract: Medical devices that include a tubular member with a plurality of braided filaments, each filament crossing another of the filaments at a respective crossing point forming sidewall and a plurality of pores in the sidewall that are sized to inhibit flow of blood through the sidewall into an aneurysm to a degree sufficient to lead to thrombosis and healing of the aneurysm when the tubular member is positioned in a blood vessel and adjacent to the aneurysm, the pores have an average pore size that is less than or equal to about 500 microns when the tubular member is in an expanded state, the filaments possessing antithrombogenic surfaces to increase antithrombogenicity of the medical device with pores substantially free of webs formed by antithrombogenic material, such that fewer than 5% of the crossing points have webs formed by antithrombogenic material thereby permitting the pores to be substantially free of webs.

    INJECTABLE SCAFFOLD FOR TREATMENT OF INTRACRANIAL ANEURYSMS AND RELATED TECHNOLOGY

    公开(公告)号:US20200061099A1

    公开(公告)日:2020-02-27

    申请号:US16669978

    申请日:2019-10-31

    Applicant: Covidien LP

    Abstract: A method for treating an aneurysm in accordance with a particular embodiment of the present technology includes intravascularly delivering a mixture including a biopolymer (e.g., chitosan) and a chemical crosslinking agent (e.g., genipin) to an aneurysm. The method further includes mixing the biopolymer and the chemical crosslinking agent to initiate chemical crosslinking of the biopolymer. The mixture is delivered to the aneurysm via a lumen and an exit port of a catheter while the chemical crosslinking is ongoing. The mixture exits the catheter as a single cohesive strand that at least partially agglomerates to form a mass occupying at least 75% of a total internal volume of the aneurysm. During delivery of the mixture, the method includes expanding a tubular flow diverter to reinforce a neck of the aneurysm.

Patent Agency Ranking